MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$752,750K
Net Income
-$66,875K
Net Profit Margin
-8.88%
EPS
-$0.47
Unit: Thousand (K) dollars
Revenue Breakdown
Insurance Carriers
Laboratory Partners
Patients
Revenue Breakdown
US
EMEA
Americas Excluding United States
Asia Pacific And Other
Revenue Breakdown
Product
Licensing And Other
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
752,750
696,644
597,939*
592,183
Cost of revenues-Product
266,597
245,203
200,451*
207,253
Cost of revenues-Licensing And Other
964
608
787*
548
Research and development
228,071
210,702
144,352*
173,412
Selling, general and administrative
327,203
327,938
249,909*
308,546
Amortization of acquired intangible assets
-
-
430*
-
Amortization of acquired intangible assets-Foresight Diagnostics Inc.
5,707
5,709
-
-
Total cost and expenses
828,542
790,160
595,928*
689,759
Gain from operations
-75,792
-93,516
2,011*
-97,576
Interest expense
890
892
934*
1,045
Interest and other income, net
9,452
9,600
12,834*
11,284
Gain before income taxes
-67,230
-84,808
13,911*
-87,337
Income tax benefit (expense)
-261
283
-60,702*
207
Net gain
-66,969
-85,091
74,613*
-87,544
Unrealized (loss) gain on available-for-sale securities, net of tax
-
-
-
100
Unrealized gain (loss) on available-for-sale securities, net of tax and foreign currency translation adjustment
94
56
22*
-
Comprehensive gain
-66,875
-85,035
74,634
-87,444
Basic EPS
-0.47
-0.6
0.546
-0.64
Diluted EPS
-0.47
-0.6
0.546
-0.64
Basic Average Shares
143,279,000
141,502,000
136,588,000
137,187,000
Diluted Average Shares
143,279,000
141,502,000
136,588,000
137,187,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
Comprehensive gain
-$66,875K
(33.81%↑ Y/Y)
Unrealized gain (loss) on
available-for-sale securities, net...
$94K
Net gain
-$66,969K
(33.65%↑ Y/Y)
Income tax benefit
(expense)
-$261K
(-194.91%↓ Y/Y)
Gain before income
taxes
-$67,230K
(33.21%↑ Y/Y)
Interest and other
income, net
$9,452K
(-11.98%↓ Y/Y)
Insurance Carriers
$705,087K
(36.38%↑ Y/Y)
Laboratory Partners
$37,745K
(70.26%↑ Y/Y)
Patients
$9,918K
(33.23%↑ Y/Y)
Gain from operations
-$75,792K
(31.33%↑ Y/Y)
Total revenues
$752,750K
(37.71%↑ Y/Y)
Interest expense
$890K
(-13.51%↓ Y/Y)
Total cost and
expenses
$828,542K
(26.12%↑ Y/Y)
Selling, general and
administrative
$327,203K
(5.36%↑ Y/Y)
Cost of
revenues-Product
$266,597K
(33.61%↑ Y/Y)
Research and development
$228,071K
(55.76%↑ Y/Y)
Amortization of acquired
intangible...
$5,707K
Cost of
revenues-Licensing And Other
$964K
(107.31%↑ Y/Y)
Buy us a coffee
natera-svg
Natera, Inc. (NTRA)
natera-svg
Natera, Inc. (NTRA)